ShareValue.ai

ShareValue scores for 300529.SHE: Valuation 49, Quality 88, Growth 53, Health 47.

300529.SHE
SZSE

Jafron Biomedical Co Ltd

CN¥15.73(+4.59%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

7% to 16%
Valuation
49
Fair Value
Price vs Value
Quality
88
Strong
Business Strength
Growth
53
Moderate
Revenue & Earnings
Health
47
Moderate
Financial Stability
Momentum
36
Bearish
Price Trend

Company Details

About

Jafron Biomedical Co.,Ltd. engages in the research, development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.

Score Analysis

AI Investment Thesis

Data as of:Jun 29, 2026
|
Last calculated:Jun 29, 2026